While the pharmaceutical industry is heavily regulated to ensure medication safety, these regulations should not hinder ...

UK digital health company RHYTHM AI has claimed FDA approval for a new version of its algorithm for mapping areas of the ...

The FDA has approved Sarclisa (isatuximab) as a first-line therapy for blood cancer multiple myeloma as a combination regimen ...

Zevra Therapeutics' Miplyffa has become the first medicine to be approved by the FDA for the ultra-rare genetic disorder ...

J&J said its latest bankruptcy bid is backed by around 83% of the 60,000-plus claimants cited in lawsuits, who are claiming ...

The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a ...

The FDA has kicked off a priority review of Genfit and Ipsen’s elafibranor as a treatment for rare cholestatic liver disease primary biliary cholangitis (PBC), setting a date of 10th June to ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Connected health stands at the intersection of healthcare and technology, where innovation is reshaping patient care. It encompasses a range of digital solutions, including telemedicine platforms ...

Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...

J&J's high expectations for Rybrevant are driven mainly by its August approval with Lazcluze, which outperformed Tagrisso in ...

The challenge persists, but, with a renewed focus from regulatory bodies and trial sponsors alike on improving enrolment ...